Učitavanje...

Agonists of growth hormone-releasing hormone (GHRH) inhibit human experimental cancers in vivo by down-regulating receptors for GHRH

The effects of the growth hormone-releasing hormone (GHRH) agonist MR409 on various human cancer cells were investigated. In H446 small cell lung cancer (SCLC) and HCC827 and H460 (non-SCLC) cells, MR409 promoted cell viability, reduced cell apoptosis, and induced the production of cellular cAMP in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Proc Natl Acad Sci U S A
Glavni autori: Schally, Andrew V., Wang, Haibo, He, Jinlin, Cai, Renzhi, Sha, Wei, Popovics, Petra, Perez, Roberto, Vidaurre, Irving, Zhang, Xianyang
Format: Artigo
Jezik:Inglês
Izdano: National Academy of Sciences 2018
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6255156/
https://ncbi.nlm.nih.gov/pubmed/30373845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1813375115
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!